-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today, the official website of CDE shows that the application for clinical trials of the new drug HEC88473 injection developed by Dongyang Sunshine has been approved by the State Food and Drug Administration by default, and it plans to carry out clinical research on type 2 diabetes and weight loss.
HEC88473 injection is the first class 1 new drug submitted by Dongyang Pharmaceutical in 2021; insulin degludec injection is a new and ultra-long-acting insulin analogue, with global sales exceeding US$1.
GLP-1R (glucagon-like peptide-1 receptor) agonists are a type of incretin peptides that can enhance glucose-stimulated insulin secretion and reduce food intake.
Fibroblast growth factor-21 (FGF21) belongs to the FGF family, which is mainly synthesized by the liver and enters the circulation in the form of endocrine.
Reference source: Mi Nei.